Interaction of pregnane X receptor with hypoxia-inducible factor-1 regulates chemoresistance of prostate cancer cells

Abstract

Aim: The nuclear pregnane X receptor (PXR) is a pivotal regulator of steroid and xenobiotics metabolism and plays an important role in shaping tumor cell responses to chemotherapy. Hypoxia within tumor tissue has multifaceted effects, including multiple drug resistance. The goal of this study was to determine whether PXR contributes to hypoxia-induced drug resistance.

Methods: Metastatic prostate cancer cells were used to study the interaction of PXR and hypoxia-inducible factor-1 (HIF-1 in drug resistance associated with hypoxia. The activities of PXR and HIF-1 were determined by assays for its reporter gene or target gene expression. Co-immunoprecipitation (Co-IP) was used to determine the interaction of PXR and HIF-1. Ablation or inhibition of PXR or HIF-1 was used to determine their roles in hypoxia-induced chemoresistance.

Results: PXR was activated by hypoxia, leading to increased expression of multidrug resistance protein 1 (MDR1). Inhibition of PXR by pharmacological compounds or depletion by shRNAs reduced the hypoxic induction of MDR1 and sensitized prostate cancer cells to chemotherapy under hypoxia. HIF-1 was required for PXR activation under hypoxia. Co-immunoprecipitation results showed that HIF-1 and PXR could physically interact with each other, leading to crosstalk between these two transcription factors.

Conclusion: PXR contributes to hypoxia-induced drug resistance in prostate cancer cells through its interaction with HIF-1.

Keywords

PXR / HIF-1 / prostate cancer / chemoresistance / multidrug resistance / MDR1 / hypoxia

References

[1] Vaupel P.Hypoxia and anemia: effects on tumor biology and treatment resistance.Transfus Clin Biol2005;12:5-10

[2] Kim JW,Dang CV.Effects of hypoxia on tumor metabolism.Cancer Metastasis Rev2007;26:291-8

[3] Ruan K,Ouyang G.Role of hypoxia in the hallmarks of human cancer.J Cell Biochem2009;107:1053-62

[4] Teicher BA.Hypoxia and drug resistance.Cancer Metastasis Rev1994;13:139-68

[5] Smith TG,Ratcliffe PJ.The human side of hypoxia-inducible factor.Br J Haematol2008;141:325-34 PMCID:PMC2408651

[6] Ryan HE,McNulty W.Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.Cancer Res60:4010-5

[7] Talks KL,Gatter KC.The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.Am J Pathol2000;157:411-21 PMCID:PMC1850121

[8] Zhong H,Laughner E.Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases.Cancer Res59:5830-5

[9] Li J,Cao Y.Knockdown of hypoxia-inducible factor-1alpha in breast carcinoma MCF-7 cells results in reduced tumor growth and increased sensitivity to methotrexate.Biochem Biophys Res Commun2006;342:1341-51

[10] Roberts DL,Cowen RL.Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells.Br J Cancer2009;101:1290-7 PMCID:PMC2768443

[11] Comerford KM,Karhausen J,Montalto MC.Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene.Cancer Res62:3387-94

[12] Monti E.HIF-1 as a target for cancer chemotherapy, chemosensitization and chemoprevention.Curr Mol Pharmacol2011;4:62-77

[13] Synold TW,Forman BM.The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux.Nat Med2001;7:584-90

[14] Chen Y,Wang MT,Nie D.Human pregnane X receptor and resistance to chemotherapy in prostate cancer.Cancer Res2007;67:10361-7

[15] Chen Y,Chen S.Regulation of drug resistance by human pregnane X receptor in breast cancer.Cancer Biol Ther2009;8:1265-72 PMCID:PMC3392171

[16] Chen Y,Guo C,Boral D.Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters.Biochem Pharmacol2012;83:1112-26 PMCID:PMC3339266

[17] Huang H,Sinz M.Inhibition of drug metabolism by blocking the activation of nuclear receptors by ketoconazole.Oncogene2007;26:258-68

[18] Fu B,Li Z,Jiang BH.Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis.Mol Cancer Ther2007;6:220-6

[19] Yuan Y,Ferguson T.Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha.J Biol Chem2003;278:15911-6

[20] Wahli W.A gut feeling of the PXR, PPAR and NF-kappaB connection.J Intern Med2008;263:613-9

[21] Jung D,Meyer UA.Pregnane X receptor is a target of farnesoid X receptor.J Biol Chem2006;281:19081-91

[22] Kodama S,Negishi M.Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes.Mol Cell Biol2004;24:7931-40 PMCID:PMC515037

[23] Jaakkola P,Tian YM.Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.Science2001;292:468-72

[24] Ke Q.Hypoxia-inducible factor-1 (HIF-1).Mol Pharmacol2006;70:1469-80

[25] Chun YS,Yeo EJ,Kim MS.A new HIF-1 alpha variant induced by zinc ion suppresses HIF-1-mediated hypoxic responses.J Cell Sci2001;114:4051-61

[26] Chun YS,Kim TY,Park JW.A dominant-negative isoform lacking exons 11 and 12 of the human hypoxia-inducible factor-1alpha gene.Biochem J2002;362:71-9 PMCID:PMC1222361